Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease

There are currently no reliable predictors of cognitive impairment in Parkinson's disease. Using both cross-sectional and longitudinal comparisons, Schulz et al. report that grey matter volume loss and increased mean diffusivity in the nucleus basalis of Meynert is predictive of cognitive impai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain (London, England : 1878) England : 1878), 2018-05, Vol.141 (5), p.1501-1516
Hauptverfasser: Schulz, Jonathan, Pagano, Gennaro, Fernández Bonfante, Juan Alberto, Wilson, Heather, Politis, Marios
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1516
container_issue 5
container_start_page 1501
container_title Brain (London, England : 1878)
container_volume 141
creator Schulz, Jonathan
Pagano, Gennaro
Fernández Bonfante, Juan Alberto
Wilson, Heather
Politis, Marios
description There are currently no reliable predictors of cognitive impairment in Parkinson's disease. Using both cross-sectional and longitudinal comparisons, Schulz et al. report that grey matter volume loss and increased mean diffusivity in the nucleus basalis of Meynert is predictive of cognitive impairment in Parkinson's disease. Abstract Currently, no reliable predictors of cognitive impairment in Parkinson's disease exist. We hypothesized that microstructural changes at grey matter T1-weighted MRI and diffusion tensor imaging in the cholinergic system nuclei and associated limbic pathways underlie cognitive impairment in Parkinson's disease. We performed a cross-sectional comparison between patients with Parkinson's disease with and without cognitive impairment. We also performed a longitudinal 36-month follow-up study of cognitively intact Parkinson's disease patients, comparing patients who remained cognitively intact to those who developed cognitive impairment. Patients with Parkinson's disease with cognitive impairment showed lower grey matter volume and increased mean diffusivity in the nucleus basalis of Meynert, compared to patients with Parkinson's disease without cognitive impairment. These results were confirmed both with region of interest and voxel-based analyses, and after partial volume correction. Lower grey matter volume and increased mean diffusivity in the nucleus basalis of Meynert was predictive for developing cognitive impairment in cognitively intact patients with Parkinson's disease, independent of other clinical and non-clinical markers of the disease. Structural and microstructural alterations in entorhinal cortex, amygdala, hippocampus, insula, and thalamus were not predictive for developing cognitive impairment in Parkinson's disease. Our findings provide evidence that degeneration of the nucleus basalis of Meynert precedes and predicts the onset of cognitive impairment, and might be used in a clinical setting as a reliable biomarker to stratify patients at higher risk of cognitive decline.
doi_str_mv 10.1093/brain/awy072
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6171218</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/brain/awy072</oup_id><sourcerecordid>2032437709</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-c06b02a288b4db4a9f9e50c74c7f0159f1bee2637ff4b4fab64017f087fddc8c3</originalsourceid><addsrcrecordid>eNp9kctv1DAQxi0EotuFG2fkWzk0dOx44-SChKq-pPI4tGfLj_FiSOxgJ0X735N2SwUXTjOj-embx0fIGwbvGXT1ick6xBP9aweSPyMrJhqoONs0z8kKAJqq7TZwQA5L-Q7ARM2bl-SAdxKYbOWKhM-z7XEu1Oii-1Bo8vQT7iLmiTrc4pLoKaRIx4wWHRaqo7svXLBToTZtY5jCHdIwjDrkAeNEQ6Rfdf4RYknxqFAXCuqCr8gLr_uCrx_jmtyen92cXlbXXy6uTj9eV1a0fKosNAa45m1rhDNCd77DDVgprPTANp1nBpE3tfReGOG1acRyiodWeudsa-s1-bDXHWczoLPLRln3asxh0Hmnkg7q304M39Q23amGScZZuwi8exTI6eeMZVJDKBb7XkdMc1Ecai5qKZfnr8nxHrU5lZLRP41hoO7dUQ_uqL07C_7279We4D92LMDRHkjz-H-p3yS-njE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2032437709</pqid></control><display><type>article</type><title>Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Schulz, Jonathan ; Pagano, Gennaro ; Fernández Bonfante, Juan Alberto ; Wilson, Heather ; Politis, Marios</creator><creatorcontrib>Schulz, Jonathan ; Pagano, Gennaro ; Fernández Bonfante, Juan Alberto ; Wilson, Heather ; Politis, Marios</creatorcontrib><description>There are currently no reliable predictors of cognitive impairment in Parkinson's disease. Using both cross-sectional and longitudinal comparisons, Schulz et al. report that grey matter volume loss and increased mean diffusivity in the nucleus basalis of Meynert is predictive of cognitive impairment in Parkinson's disease. Abstract Currently, no reliable predictors of cognitive impairment in Parkinson's disease exist. We hypothesized that microstructural changes at grey matter T1-weighted MRI and diffusion tensor imaging in the cholinergic system nuclei and associated limbic pathways underlie cognitive impairment in Parkinson's disease. We performed a cross-sectional comparison between patients with Parkinson's disease with and without cognitive impairment. We also performed a longitudinal 36-month follow-up study of cognitively intact Parkinson's disease patients, comparing patients who remained cognitively intact to those who developed cognitive impairment. Patients with Parkinson's disease with cognitive impairment showed lower grey matter volume and increased mean diffusivity in the nucleus basalis of Meynert, compared to patients with Parkinson's disease without cognitive impairment. These results were confirmed both with region of interest and voxel-based analyses, and after partial volume correction. Lower grey matter volume and increased mean diffusivity in the nucleus basalis of Meynert was predictive for developing cognitive impairment in cognitively intact patients with Parkinson's disease, independent of other clinical and non-clinical markers of the disease. Structural and microstructural alterations in entorhinal cortex, amygdala, hippocampus, insula, and thalamus were not predictive for developing cognitive impairment in Parkinson's disease. Our findings provide evidence that degeneration of the nucleus basalis of Meynert precedes and predicts the onset of cognitive impairment, and might be used in a clinical setting as a reliable biomarker to stratify patients at higher risk of cognitive decline.</description><identifier>ISSN: 0006-8950</identifier><identifier>ISSN: 1460-2156</identifier><identifier>EISSN: 1460-2156</identifier><identifier>DOI: 10.1093/brain/awy072</identifier><identifier>PMID: 29701787</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Aged ; Basal Nucleus of Meynert - diagnostic imaging ; Cerebral Cortex - diagnostic imaging ; Cognitive Dysfunction - diagnostic imaging ; Cognitive Dysfunction - etiology ; Diffusion Tensor Imaging ; Female ; Gray Matter - diagnostic imaging ; Humans ; Image Processing, Computer-Assisted ; Male ; Middle Aged ; Nerve Degeneration - diagnostic imaging ; Nerve Degeneration - etiology ; Neuropsychological Tests ; Original ; Parkinson Disease - complications</subject><ispartof>Brain (London, England : 1878), 2018-05, Vol.141 (5), p.1501-1516</ispartof><rights>The Author(s) (2018). Published by Oxford University Press on behalf of the Guarantors of Brain. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-c06b02a288b4db4a9f9e50c74c7f0159f1bee2637ff4b4fab64017f087fddc8c3</citedby><cites>FETCH-LOGICAL-c482t-c06b02a288b4db4a9f9e50c74c7f0159f1bee2637ff4b4fab64017f087fddc8c3</cites><orcidid>0000-0001-8530-7113 ; 0000-0002-6247-8988</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,1579,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29701787$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schulz, Jonathan</creatorcontrib><creatorcontrib>Pagano, Gennaro</creatorcontrib><creatorcontrib>Fernández Bonfante, Juan Alberto</creatorcontrib><creatorcontrib>Wilson, Heather</creatorcontrib><creatorcontrib>Politis, Marios</creatorcontrib><title>Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease</title><title>Brain (London, England : 1878)</title><addtitle>Brain</addtitle><description>There are currently no reliable predictors of cognitive impairment in Parkinson's disease. Using both cross-sectional and longitudinal comparisons, Schulz et al. report that grey matter volume loss and increased mean diffusivity in the nucleus basalis of Meynert is predictive of cognitive impairment in Parkinson's disease. Abstract Currently, no reliable predictors of cognitive impairment in Parkinson's disease exist. We hypothesized that microstructural changes at grey matter T1-weighted MRI and diffusion tensor imaging in the cholinergic system nuclei and associated limbic pathways underlie cognitive impairment in Parkinson's disease. We performed a cross-sectional comparison between patients with Parkinson's disease with and without cognitive impairment. We also performed a longitudinal 36-month follow-up study of cognitively intact Parkinson's disease patients, comparing patients who remained cognitively intact to those who developed cognitive impairment. Patients with Parkinson's disease with cognitive impairment showed lower grey matter volume and increased mean diffusivity in the nucleus basalis of Meynert, compared to patients with Parkinson's disease without cognitive impairment. These results were confirmed both with region of interest and voxel-based analyses, and after partial volume correction. Lower grey matter volume and increased mean diffusivity in the nucleus basalis of Meynert was predictive for developing cognitive impairment in cognitively intact patients with Parkinson's disease, independent of other clinical and non-clinical markers of the disease. Structural and microstructural alterations in entorhinal cortex, amygdala, hippocampus, insula, and thalamus were not predictive for developing cognitive impairment in Parkinson's disease. Our findings provide evidence that degeneration of the nucleus basalis of Meynert precedes and predicts the onset of cognitive impairment, and might be used in a clinical setting as a reliable biomarker to stratify patients at higher risk of cognitive decline.</description><subject>Aged</subject><subject>Basal Nucleus of Meynert - diagnostic imaging</subject><subject>Cerebral Cortex - diagnostic imaging</subject><subject>Cognitive Dysfunction - diagnostic imaging</subject><subject>Cognitive Dysfunction - etiology</subject><subject>Diffusion Tensor Imaging</subject><subject>Female</subject><subject>Gray Matter - diagnostic imaging</subject><subject>Humans</subject><subject>Image Processing, Computer-Assisted</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nerve Degeneration - diagnostic imaging</subject><subject>Nerve Degeneration - etiology</subject><subject>Neuropsychological Tests</subject><subject>Original</subject><subject>Parkinson Disease - complications</subject><issn>0006-8950</issn><issn>1460-2156</issn><issn>1460-2156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kctv1DAQxi0EotuFG2fkWzk0dOx44-SChKq-pPI4tGfLj_FiSOxgJ0X735N2SwUXTjOj-embx0fIGwbvGXT1ick6xBP9aweSPyMrJhqoONs0z8kKAJqq7TZwQA5L-Q7ARM2bl-SAdxKYbOWKhM-z7XEu1Oii-1Bo8vQT7iLmiTrc4pLoKaRIx4wWHRaqo7svXLBToTZtY5jCHdIwjDrkAeNEQ6Rfdf4RYknxqFAXCuqCr8gLr_uCrx_jmtyen92cXlbXXy6uTj9eV1a0fKosNAa45m1rhDNCd77DDVgprPTANp1nBpE3tfReGOG1acRyiodWeudsa-s1-bDXHWczoLPLRln3asxh0Hmnkg7q304M39Q23amGScZZuwi8exTI6eeMZVJDKBb7XkdMc1Ecai5qKZfnr8nxHrU5lZLRP41hoO7dUQ_uqL07C_7279We4D92LMDRHkjz-H-p3yS-njE</recordid><startdate>20180501</startdate><enddate>20180501</enddate><creator>Schulz, Jonathan</creator><creator>Pagano, Gennaro</creator><creator>Fernández Bonfante, Juan Alberto</creator><creator>Wilson, Heather</creator><creator>Politis, Marios</creator><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8530-7113</orcidid><orcidid>https://orcid.org/0000-0002-6247-8988</orcidid></search><sort><creationdate>20180501</creationdate><title>Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease</title><author>Schulz, Jonathan ; Pagano, Gennaro ; Fernández Bonfante, Juan Alberto ; Wilson, Heather ; Politis, Marios</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-c06b02a288b4db4a9f9e50c74c7f0159f1bee2637ff4b4fab64017f087fddc8c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Basal Nucleus of Meynert - diagnostic imaging</topic><topic>Cerebral Cortex - diagnostic imaging</topic><topic>Cognitive Dysfunction - diagnostic imaging</topic><topic>Cognitive Dysfunction - etiology</topic><topic>Diffusion Tensor Imaging</topic><topic>Female</topic><topic>Gray Matter - diagnostic imaging</topic><topic>Humans</topic><topic>Image Processing, Computer-Assisted</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nerve Degeneration - diagnostic imaging</topic><topic>Nerve Degeneration - etiology</topic><topic>Neuropsychological Tests</topic><topic>Original</topic><topic>Parkinson Disease - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schulz, Jonathan</creatorcontrib><creatorcontrib>Pagano, Gennaro</creatorcontrib><creatorcontrib>Fernández Bonfante, Juan Alberto</creatorcontrib><creatorcontrib>Wilson, Heather</creatorcontrib><creatorcontrib>Politis, Marios</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Brain (London, England : 1878)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schulz, Jonathan</au><au>Pagano, Gennaro</au><au>Fernández Bonfante, Juan Alberto</au><au>Wilson, Heather</au><au>Politis, Marios</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease</atitle><jtitle>Brain (London, England : 1878)</jtitle><addtitle>Brain</addtitle><date>2018-05-01</date><risdate>2018</risdate><volume>141</volume><issue>5</issue><spage>1501</spage><epage>1516</epage><pages>1501-1516</pages><issn>0006-8950</issn><issn>1460-2156</issn><eissn>1460-2156</eissn><abstract>There are currently no reliable predictors of cognitive impairment in Parkinson's disease. Using both cross-sectional and longitudinal comparisons, Schulz et al. report that grey matter volume loss and increased mean diffusivity in the nucleus basalis of Meynert is predictive of cognitive impairment in Parkinson's disease. Abstract Currently, no reliable predictors of cognitive impairment in Parkinson's disease exist. We hypothesized that microstructural changes at grey matter T1-weighted MRI and diffusion tensor imaging in the cholinergic system nuclei and associated limbic pathways underlie cognitive impairment in Parkinson's disease. We performed a cross-sectional comparison between patients with Parkinson's disease with and without cognitive impairment. We also performed a longitudinal 36-month follow-up study of cognitively intact Parkinson's disease patients, comparing patients who remained cognitively intact to those who developed cognitive impairment. Patients with Parkinson's disease with cognitive impairment showed lower grey matter volume and increased mean diffusivity in the nucleus basalis of Meynert, compared to patients with Parkinson's disease without cognitive impairment. These results were confirmed both with region of interest and voxel-based analyses, and after partial volume correction. Lower grey matter volume and increased mean diffusivity in the nucleus basalis of Meynert was predictive for developing cognitive impairment in cognitively intact patients with Parkinson's disease, independent of other clinical and non-clinical markers of the disease. Structural and microstructural alterations in entorhinal cortex, amygdala, hippocampus, insula, and thalamus were not predictive for developing cognitive impairment in Parkinson's disease. Our findings provide evidence that degeneration of the nucleus basalis of Meynert precedes and predicts the onset of cognitive impairment, and might be used in a clinical setting as a reliable biomarker to stratify patients at higher risk of cognitive decline.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>29701787</pmid><doi>10.1093/brain/awy072</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0001-8530-7113</orcidid><orcidid>https://orcid.org/0000-0002-6247-8988</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-8950
ispartof Brain (London, England : 1878), 2018-05, Vol.141 (5), p.1501-1516
issn 0006-8950
1460-2156
1460-2156
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6171218
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Aged
Basal Nucleus of Meynert - diagnostic imaging
Cerebral Cortex - diagnostic imaging
Cognitive Dysfunction - diagnostic imaging
Cognitive Dysfunction - etiology
Diffusion Tensor Imaging
Female
Gray Matter - diagnostic imaging
Humans
Image Processing, Computer-Assisted
Male
Middle Aged
Nerve Degeneration - diagnostic imaging
Nerve Degeneration - etiology
Neuropsychological Tests
Original
Parkinson Disease - complications
title Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T04%3A15%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nucleus%20basalis%20of%20Meynert%20degeneration%20precedes%20and%20predicts%20cognitive%20impairment%20in%20Parkinson's%20disease&rft.jtitle=Brain%20(London,%20England%20:%201878)&rft.au=Schulz,%20Jonathan&rft.date=2018-05-01&rft.volume=141&rft.issue=5&rft.spage=1501&rft.epage=1516&rft.pages=1501-1516&rft.issn=0006-8950&rft.eissn=1460-2156&rft_id=info:doi/10.1093/brain/awy072&rft_dat=%3Cproquest_pubme%3E2032437709%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2032437709&rft_id=info:pmid/29701787&rft_oup_id=10.1093/brain/awy072&rfr_iscdi=true